Kwangmu Co.,Ltd. (KOSDAQ:029480)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	138,496	136,604	97,136	111,774	156,453	45,709
Market Cap Growth	-34.56%	40.63%	-13.10%	-28.56%	242.28%	-9.81%
Enterprise Value	-6,763	-23,942	35,141	91,727	149,973	54,289
Last Close Price	2540.00	2485.00	2030.00	3120.00	6875.00	2875.00
PE Ratio	-	1.31	13.34	-	-	-
PS Ratio	21.78	20.93	4.01	1.43	8.27	1.82
PB Ratio	0.72	0.59	0.85	1.40	3.07	1.89
P/TBV Ratio	0.73	0.59	0.86	1.40	3.10	1.99
P/FCF Ratio	-	36.70	3.54	-	-	-
P/OCF Ratio	-	29.13	3.40	-	-	-
EV/Sales Ratio	-	-	1.45	1.17	7.93	2.16
EV/EBITDA Ratio	-	-	-	29.54	-	-
EV/EBIT Ratio	-	-	-	38.32	-	-
EV/FCF Ratio	0.74	-	1.28	-	-	-
Debt / Equity Ratio	0.11	0.09	0.08	0.51	0.86	0.30
Debt / EBITDA Ratio	-	-	-	13.07	-	-
Debt / FCF Ratio	-	5.36	0.32	-	-	-
Asset Turnover	0.03	0.03	0.18	0.65	0.27	0.50
Inventory Turnover	40.83	98.49	75.70	214.52	117.52	65.88
Quick Ratio	5.29	4.77	5.34	2.08	1.63	1.11
Current Ratio	5.44	4.88	6.28	2.10	1.64	1.31
Return on Equity (ROE)	-14.62%	60.03%	7.51%	-12.18%	-1.86%	-82.80%
Return on Assets (ROA)	-1.40%	-1.43%	-1.23%	1.25%	-0.65%	-3.81%
Return on Capital (ROIC)	-1.50%	-1.57%	-1.34%	1.39%	-0.73%	-4.94%
Return on Capital Employed (ROCE)	-	-	-	3.00%	-	-
Earnings Yield	-21.07%	76.26%	7.50%	-6.59%	-0.48%	-41.99%
FCF Yield	-6.61%	2.73%	28.28%	-31.62%	-0.85%	-4.22%
Buyback Yield / Dilution	-1.54%	-8.55%	-79.01%	-64.27%	-36.54%	-58.30%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.